ArriVent BioPharma Inc.

AVBP | NASDAQ

Price Alert Chart Builder DCF Calculator

$29.74

+$0.84 (+2.91%)

At close: Sep 21, 2026, 4:00 PM ET

$29.70

-$0.04 (-0.13%)

Pre-market: Sep 22, 2026, 8:21 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-175.94M	-156.87M	-177.53M	-162.42M	-148.33M	-140.41M	-94.31M	-93.72M	-86.21M	-83.09M	-74.59M	-61.91M	-56.97M	-41.73M	-36.91M	-26.46M	-14.7M	-7.35M
Interest Income	12.21M	11.63M	11.23M	11.02M	11.35M	12.95M	13.82M	12.67M	11.32M	8.51M	5.26M	3.33M	1.02M	n/a	n/a	n/a	n/a	n/a
Pretax Income	-163.74M	-145.24M	-166.31M	-151.4M	-136.98M	-127.46M	-80.49M	-81.05M	-74.89M	-74.58M	-69.33M	-58.58M	-55.95M	-41.73M	-36.91M	-26.46M	-14.7M	-7.35M
Net Income	-163.74M	-145.24M	-166.31M	-151.4M	-136.98M	-127.46M	-80.49M	-81.05M	-74.89M	-74.58M	-69.33M	-58.58M	-55.95M	-41.73M	-36.91M	-26.46M	-14.7M	-7.35M
Selling & General & Admin	31.64M	27.19M	24.18M	21.08M	19.07M	17.09M	15.3M	14.87M	13.16M	11.47M	9.71M	8.39M	7.64M	6.91M	6.47M	4.68M	3M	1.5M
Research & Development	144.3M	129.68M	153.35M	141.34M	129.26M	123.32M	79M	78.85M	73.04M	71.62M	64.88M	53.52M	49.33M	34.82M	30.43M	21.79M	11.7M	5.85M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	175.94M	156.87M	177.53M	162.42M	148.33M	140.41M	94.31M	93.72M	86.21M	83.09M	74.59M	61.91M	56.97M	41.73M	36.91M	26.46M	14.7M	7.35M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	175.94M	156.87M	177.53M	162.42M	148.33M	140.41M	94.31M	93.72M	86.21M	83.09M	74.59M	61.91M	56.97M	41.73M	36.91M	26.46M	14.7M	7.35M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	47.61M	45.07M	38.46M	41.91M	35.01M	33.9M	33.58M	33.58M	33.51M	33.49M	33.49M	33.49M	33.49M	33.49M	33.49M	33.49M	1.28M	1.28M
Shares Outstanding (Diluted)	47.61M	45.07M	38.46M	41.91M	35.01M	33.9M	33.58M	33.58M	33.51M	33.49M	33.49M	33.49M	33.49M	33.49M	33.49M	33.49M	1.28M	1.28M
EPS (Basic)	-3.68	-3.53	-4.47	-4.24	-4.02	-3.77	-2.39	-2.41	-2.23	-2.22	-2.06	-1.74	-1.66	-6.78	-12.18	-11.87	-11.52	-5.76
EPS (Diluted)	-3.68	-3.53	-4.47	-4.24	-4.02	-3.77	-2.39	-2.41	-2.23	-2.22	-2.06	-1.74	-1.66	-6.78	-12.18	-11.87	-11.52	-5.76
EBITDA	-163.74M	-145.24M	-166.31M	-151.4M	-136.98M	-127.46M	-80.49M	-81.05M	-74.89M	-74.58M	-57.16M	-35.97M	-21.57M	n/a	n/a	n/a	n/a	n/a
EBIT	-163.74M	-145.24M	-166.31M	-151.4M	-136.98M	-127.46M	-80.49M	-81.05M	-74.89M	-74.58M	-69.33M	-58.58M	-55.95M	-41.73M	-36.91M	-26.46M	-14.7M	-7.35M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	12.17M	22.61M	34.38M	41.73M	36.91M	26.46M	14.7M	7.35M